top of page

Patients Are Waiting.
Fail Faster Toward The Cure.

About

Organoids For Neuroscience

PROBLEM

Neurodegenerative diseases, especially Alzheimers, are challenging for drug development. Real drug solutions do not yet exist. One of the major obstacles is not being able to test potential new drugs on humans during the preclinical stage. We believe that our technology is the solution.

Light%20bulb%20icon_edited.jpg
SOLUTION

We strongly believe that our novel 4D bioprinting technology combined with stem cells will make organoid technology a necessity during preclinical

drug development.

Technology

Our Technology

01 / RELIABLE
02 / RELEVANT
Screen Shot 2021-01-28 at 9.37.53 AM.png

Variability among organoids creates unreliable data. We offer a new 4D bioprinting technology that will bring control and consistency to organoid systems.

Screen%20Shot%202021-01-28%20at%209.38_e

Two dimensional cell cultures and animal models are not physiologically representative of humans. Using actual human cells, our 4D bioprinted live organoids will be ideal to model human diseases.

03 / SCALABLE
Screen Shot 2021-01-28 at 9.38.05 AM.png

Our new high speed, 4D bioprinting technology will revolutionize high throughput drug screening platforms for brain organoids and augment preclinical outcomes.

Product

Product & Services

Organoids Pic_edited.png
Bank of Live Organoid
Disease Models

​Genetic mutations relevant to the disease

 

Provided at any stage of development

​

Delivered directly to the customer's lab

Drug Screening Pic.png
Organoid Drug Development Assays
  • Order live reliable Organoids delivered to your doorstep and ready to use.

 

  • Order Organoids with a genetic mutation relevant to your Disease.

 

  • Order Organoids at any stage of their development (4 weeks to x years old )

Conduct the following test for customer specific compounds:

​

Drug Screening

​

Dose Response

​​

Toxicity Testing

Team

Meet the Team

PXL_20210125_013716063_edited.png

Renaud Schuck, Ph.D

Co-Founder | CEO

​

Neuroscientist with expertise

in optics and 4D bioprinting

Imperial College London Ph.D

Jariel%20Bytheway%20Headshot%202019_edit

Jariel Bytheway

Co-Founder | CBO

​

Corporate Strategy and Operations expertise

in Aerospace and Life Sciences

Yale MBA and UCLA Alumnus

2_edited_edited.jpg

Christopher Lovejoy, Ph.D

Organoids Specialist

​

Neuroscientist with expertise in organoids 

and neurodegenerative diseases

University College London Ph.D

Location
CA_edited_edited_edited_edited_edited_ed
Red_star_edited.png
San Francisco, CA
Seattle, WA
WA%20Pic_edited.png
Red_star_edited.png

Learn More

Thank you for your message! You'll hear from us soon.

Contact Us
bottom of page